Eduard Roussel

1.5k total citations
65 papers, 606 citations indexed

About

Eduard Roussel is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Eduard Roussel has authored 65 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pulmonary and Respiratory Medicine, 28 papers in Surgery and 27 papers in Molecular Biology. Recurrent topics in Eduard Roussel's work include Renal cell carcinoma treatment (51 papers), Renal and related cancers (27 papers) and Bladder and Urothelial Cancer Treatments (18 papers). Eduard Roussel is often cited by papers focused on Renal cell carcinoma treatment (51 papers), Renal and related cancers (27 papers) and Bladder and Urothelial Cancer Treatments (18 papers). Eduard Roussel collaborates with scholars based in Belgium, Italy and France. Eduard Roussel's co-authors include Maarten Albersen, Umberto Capitanio, Riccardo Campi, Riccardo Bertolo, Selçuk Erdem, Benoit Beuselinck, Nicola Pavan, Önder Kara, Alexandre Ingels and Michele Marchioni and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Eduard Roussel

63 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduard Roussel Belgium 13 421 237 183 118 92 65 606
Önder Kara Türkiye 16 624 1.5× 323 1.4× 251 1.4× 86 0.7× 58 0.6× 68 748
Sudhir Isharwal United States 15 413 1.0× 214 0.9× 123 0.7× 103 0.9× 50 0.5× 37 567
Leonardo D. Borregales United States 14 390 0.9× 178 0.8× 185 1.0× 110 0.9× 68 0.7× 33 470
Andres Correa United States 13 296 0.7× 147 0.6× 241 1.3× 95 0.8× 74 0.8× 57 533
Yuval Freifeld United States 15 397 0.9× 148 0.6× 225 1.2× 100 0.8× 66 0.7× 36 545
Clara Cerrato Italy 12 344 0.8× 167 0.7× 121 0.7× 60 0.5× 85 0.9× 70 523
David J. Paulucci United States 15 488 1.2× 268 1.1× 188 1.0× 74 0.6× 59 0.6× 47 583
Yuto Matsushita Japan 14 354 0.8× 87 0.4× 237 1.3× 81 0.7× 80 0.9× 74 524
A. De La Taille France 13 533 1.3× 222 0.9× 142 0.8× 95 0.8× 112 1.2× 56 724
Stephan Buse Germany 13 426 1.0× 195 0.8× 153 0.8× 89 0.8× 65 0.7× 45 596

Countries citing papers authored by Eduard Roussel

Since Specialization
Citations

This map shows the geographic impact of Eduard Roussel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduard Roussel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduard Roussel more than expected).

Fields of papers citing papers by Eduard Roussel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduard Roussel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduard Roussel. The network helps show where Eduard Roussel may publish in the future.

Co-authorship network of co-authors of Eduard Roussel

This figure shows the co-authorship network connecting the top 25 collaborators of Eduard Roussel. A scholar is included among the top collaborators of Eduard Roussel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduard Roussel. Eduard Roussel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Warren, Hannah, Naila Khalil, Giuseppe Basile, et al.. (2025). A Systematic Review and Meta-analysis of Oncological Outcomes of Treated and Untreated Complex Cystic Renal Masses. European Urology Focus.
2.
Nissen, Peter H., Frede Donskov, Agnieszka Woźniak, et al.. (2024). Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism. Clinical Genitourinary Cancer. 22(5). 102180–102180. 1 indexed citations
3.
Kinget, Lisa, Eduard Roussel, Philip R. Debruyne, et al.. (2024). Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab. Acta Oncologica. 63. 658–668. 2 indexed citations
4.
5.
Marandino, Laura, Riccardo Bertolo, Alexandre Ingels, et al.. (2023). Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives. Diagnostics. 13(13). 2294–2294. 9 indexed citations
6.
Borregales, Leonardo D., Alessio Pecoraro, Eduard Roussel, et al.. (2023). Morbidity of elective surgery for localized renal masses among elderly patients: A contemporary multicenter study. European Journal of Surgical Oncology. 49(10). 107014–107014. 4 indexed citations
7.
Muselaers, Stijn, Daniele Amparore, Riccardo Bertolo, et al.. (2023). Optimizing postoperative follow-up in RCC patients: why does it always have to be black and white?. Minerva Urology and Nephrology. 74(6). 822–824. 5 indexed citations
8.
Paciotti, Marco, Carlo Andrea Bravi, Angelo Mottaran, et al.. (2023). Nerve‐sparing robot‐assisted radical prostatectomy with the HUGO™ robot‐assisted surgery system using the ‘Aalst technique’. British Journal of Urology. 132(2). 227–230. 15 indexed citations
9.
Roussel, Eduard, Riccardo Campi, Daniele Amparore, et al.. (2022). Expanding the Role of Ultrasound for the Characterization of Renal Masses. Journal of Clinical Medicine. 11(4). 1112–1112. 7 indexed citations
10.
Muselaers, Stijn, Selçuk Erdem, Riccardo Bertolo, et al.. (2022). PSMA PET/CT in Renal Cell Carcinoma: An Overview of Current Literature. Journal of Clinical Medicine. 11(7). 1829–1829. 24 indexed citations
11.
Carbonara, Umberto, Daniele Amparore, Cosimo Gentile, et al.. (2022). Current strategies to diagnose and manage positive surgical margins and local recurrence after partial nephrectomy. Asian journal of urology. 9(3). 227–242. 6 indexed citations
12.
13.
Kinget, Lisa, Oliver Bechter, Kevin Punie, et al.. (2021). Multitumor Case Series of Germline BRCA1, BRCA2 and CHEK2-Mutated Patients Responding Favorably on Immune Checkpoint Inhibitors. Current Oncology. 28(5). 3227–3239. 3 indexed citations
14.
Kinget, Lisa, Eduard Roussel, Diether Lambrechts, et al.. (2021). MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma. Cancers. 13(7). 1554–1554. 11 indexed citations
15.
Kinget, Lisa, Eduard Roussel, Diether Lambrechts, et al.. (2021). 689P Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC). Annals of Oncology. 32. S706–S706. 2 indexed citations
16.
Beuselinck, Benoit, Oliver Bechter, Maarten Albersen, et al.. (2020). Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma. European Journal of Clinical Pharmacology. 76(9). 1273–1280. 10 indexed citations
17.
Roussel, Eduard, Giorgio Bozzini, Asıf Muneer, et al.. (2020). Predictors of local recurrence and its impact on survival after glansectomy for penile cancer: time to challenge the dogma?. British Journal of Urology. 127(5). 606–613. 23 indexed citations
18.
Verbiest, Annelies, Vincent van Hoef, Cristina Rodríguez‐Antona, et al.. (2020). MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets. PLoS ONE. 15(9). e0238809–e0238809. 5 indexed citations
19.
Verbiest, Annelies, Eduard Roussel, Lorenzo Tosco, et al.. (2020). Long-Term Outcomes in Clear-Cell Renal Cell Carcinoma Patients Treated with Complete Metastasectomy. Lirias (KU Leuven). 4(4). 177–183. 3 indexed citations
20.
Meylan, Maxime, Benoit Beuselinck, Cécile Dalban, et al.. (2020). 700O Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N). Annals of Oncology. 31. S553–S553. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Önder Kara Breakdown of academic impact, for papers by Sudhir Isharwal Breakdown of academic impact, for papers by Leonardo D. Borregales Breakdown of academic impact, for papers by Andres Correa Breakdown of academic impact, for papers by Yuval Freifeld Breakdown of academic impact, for papers by Clara Cerrato Breakdown of academic impact, for papers by David J. Paulucci Breakdown of academic impact, for papers by Yuto Matsushita Breakdown of academic impact, for papers by A. De La Taille Breakdown of academic impact, for papers by Stephan Buse
Rankless by CCL
2026